FibroGen, Inc.
FGEN
$10.48
$0.131.26%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 98.77% | 95.84% | 83.26% | 58.60% | 47.76% |
| Total Depreciation and Amortization | -72.00% | -71.75% | -72.89% | -60.77% | -47.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -49.17% | -66.36% | -66.76% | -57.56% | -61.51% |
| Change in Net Operating Assets | 45.25% | 15.58% | 0.27% | 70.47% | 22.46% |
| Cash from Operations | 88.40% | 72.14% | 56.19% | 63.96% | 36.18% |
| Capital Expenditure | 74.23% | 87.07% | 89.44% | 85.54% | 64.85% |
| Sale of Property, Plant, and Equipment | 34,666.67% | -- | -- | 42,100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -100.00% | -100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -99.12% | -28.07% | -19.49% | -8.47% | 37.72% |
| Cash from Investing | -98.70% | -26.37% | -18.00% | -6.92% | 39.17% |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Repaid | 77.08% | 89.81% | 91.74% | 86.00% | 86.70% |
| Issuance of Common Stock | -85.71% | -99.32% | -99.73% | -99.70% | -99.70% |
| Repurchase of Common Stock | 24.02% | -55.56% | -- | 43.80% | 87.32% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 98.32% | -- | -100.00% | -100.00% |
| Cash from Financing | 45.39% | -100.20% | -100.21% | -100.29% | -100.24% |
| Foreign Exchange rate Adjustments | -86.85% | 173.07% | 122.11% | 196.37% | 159.93% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -75.83% | 100.56% | 72.60% | 128.79% | 21.76% |